Screener
Pfizer PFE Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Pfizer’s reported figures.
The source filing: Pfizer’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 7:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000078003-26-000054
FAQ
- What is Pfizer's free cash flow?
- Pfizer (PFE) reported free cash flow of $2.18B in Q1 2026.
- How has Pfizer's free cash flow changed year-over-year?
- Pfizer's free cash flow increased by 23.0% year-over-year, from $1.77B to $2.18B.
- What is the long-term trend for Pfizer's free cash flow?
- Over 3 years (2021 to 2024), Pfizer's free cash flow has grown at a -30.9% compound annual growth rate (CAGR), from $29.87B to $9.84B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Pfizer's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude